Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis

J Rheumatol. 2011 Mar;38(3):581-3. doi: 10.3899/jrheum.101013.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Infliximab
  • Janus Kinase 2 / genetics
  • Male
  • Polycythemia / chemically induced*
  • Spondylitis, Ankylosing / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab
  • JAK2 protein, human
  • Janus Kinase 2